+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biological Reagents Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6120566
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biological Reagents Market is projected to reach USD 26.60 Billion in 2026. It is expected to continue growing at a CAGR of 7.42%, reaching USD 41.23 Billion by 2032.

Biological Reagents: Executive Summary

Biological reagents are essential inputs for research, diagnostics, biomanufacturing, quality control, and life-science development. Demand is shaped by expanding molecular workflows, increasingly complex assay requirements, stricter validation expectations, and the need for reproducible performance across laboratories and production settings. The market spans enzymes, antibodies, nucleic-acid reagents, cell-culture components, buffers, stains, and related materials used across discovery and applied biological testing.

Standardization and Workflow Integration Are Reshaping Biological Reagents

The landscape is shifting from stand-alone reagent purchases toward integrated, application-specific workflows. Users increasingly value lot consistency, traceability, compatibility with automated platforms, and documentation that supports regulatory or quality requirements. Cold-chain management, contamination control, sustainable packaging, and dependable technical support are also becoming more important as laboratories adopt higher-throughput and more distributed operating models.

Artificial Intelligence Is Accelerating Reagent Selection and Quality Control

Artificial intelligence is influencing biological-reagent development and use by helping researchers interpret complex datasets, optimize experimental conditions, and identify suitable reagent combinations. Machine-learning tools can support assay design, image analysis, biomarker discovery, and anomaly detection in laboratory operations. However, effective adoption depends on high-quality training data, transparent validation, interoperable digital records, and human oversight, particularly where reagent performance affects clinical, manufacturing, or regulated decisions.

Regional Insights: Mature Infrastructure Meets Uneven Access

North America combines advanced research infrastructure, strong biotechnology activity, and broad adoption of automated laboratory workflows. Europe emphasizes quality systems, sustainability, and cross-border research coordination. Asia-Pacific is supported by expanding research capacity, biomanufacturing development, and growing demand for locally resilient supply chains. Latin America is advancing through academic, clinical, and agricultural applications while continuing to address distribution and infrastructure constraints. The Middle East is investing in research, healthcare modernization, and biotechnology capabilities. Africa presents meaningful opportunities linked to diagnostics, public-health research, and food or agricultural science, with access, logistics, and technical capacity remaining central considerations.

Group Insights: Cooperation, Regulation, and Supply Resilience

ASEAN reflects varied laboratory maturity and an increasing focus on regional manufacturing and research connectivity. BRICS economies are strengthening domestic science and biotechnology capabilities while seeking more resilient access to critical inputs. The European Union emphasizes harmonized standards, sustainability, and collaborative research. G7 countries remain influential in advanced research, quality expectations, and technology adoption. GCC markets are developing life-science infrastructure and specialized healthcare capacity. NATO members are relevant to preparedness, biomedical security, and resilient supply planning, although national regulatory and procurement environments remain distinct.

Country Insights: Diverse Priorities Across Major Research Markets

Australia supports biological-reagent demand through biomedical research, agriculture, and public-health applications. Brazil combines strong agricultural and health-science use cases with logistical complexity. Canada benefits from research institutions and biotechnology activity. China is expanding domestic capabilities across research, diagnostics, and biomanufacturing. France, Germany, Italy, and Spain emphasize regulated laboratory practice, academic research, and industrial life sciences within a coordinated European context. India is broadening research, diagnostics, and manufacturing capacity. Japan prioritizes precision, quality, and advanced laboratory automation. Mexico is developing research and healthcare applications while strengthening supply access. Russia retains activity in research and healthcare settings amid distinct trade and procurement conditions. South Korea combines advanced technology capabilities with strong biomedical and industrial research. The United Kingdom remains a significant center for life-science research and translational applications. The United States has extensive demand across research, diagnostics, biopharmaceutical development, and laboratory services.

Action Priorities for Biological-Reagent Industry Leaders

Leaders should prioritize reproducibility by strengthening lot-release testing, reference materials, stability programs, and transparent performance documentation. They should design portfolios around complete workflows rather than isolated products, with validated compatibility across instruments and software. Regional supply resilience can be improved through qualified secondary sources, localized inventory, cold-chain monitoring, and scenario-based continuity planning. Investment in digital product records and responsible artificial-intelligence tools should be paired with cybersecurity, auditability, and expert review. Finally, customer segmentation by application, laboratory maturity, and regulatory need can improve technical support, training, and adoption.

Research Methodology for the Biological-Reagents Executive Summary

This summary uses a structured qualitative assessment of the biological-reagents domain, organized around applications, technology shifts, operational requirements, regional conditions, and international groupings. Insights are framed from established industry characteristics and observable developments in laboratory automation, biotechnology, diagnostics, quality management, supply-chain resilience, and artificial-intelligence adoption. Regional, group, and country narratives compare infrastructure, policy context, research capacity, healthcare needs, manufacturing development, and logistics without presenting market estimates, shares, forecasts, or company-specific claims.

Conclusion: Reproducibility and Resilience Define the Next Phase

Biological reagents remain foundational to modern life-science workflows, but competitive advantage increasingly depends on more than biological performance alone. Reliable quality, application fit, digital traceability, resilient fulfillment, sustainability, and validated integration with automated and AI-enabled systems will shape user decisions. Organizations that combine scientific rigor with regional sensitivity and disciplined operational execution will be best positioned to support the evolving needs of research, diagnostics, biomanufacturing, and public-health laboratories.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biological Reagents Market, by Product Type
7.1. Introduction
7.2. Antibodies
7.2.1. Monoclonal
7.2.1.1. Mouse
7.2.1.2. Rabbit
7.2.2. Polyclonal
7.2.2.1. Goat
7.2.2.2. Rabbit
7.3. Cell Culture Media & Sera
7.3.1. Basal Media
7.3.2. Sera
7.3.3. Supplements
7.4. Enzymes
7.4.1. Ligases
7.4.2. Polymerases
7.4.3. Restriction Enzymes
7.5. Kits & Assays
7.5.1. Elisa Kits
7.5.2. Immunoassay Kits
7.5.3. Pcr Kits
7.5.4. Sequencing Kits
7.6. Nucleic Acids
7.6.1. Dna
7.6.2. Oligonucleotides
7.6.3. Rna
7.7. Probes & Dyes
7.7.1. Chromogenic Dyes
7.7.2. Fluorescent Probes
7.7.3. Radioactive Probes
8. Biological Reagents Market, by Technology
8.1. Introduction
8.2. Flow Cytometry
8.3. Labeling & Detection
8.3.1. Colorimetry
8.3.2. Fluorescence
8.3.3. Luminescence
8.4. Microarray
8.5. Pcr & Qpcr
8.6. Separation & Purification
8.6.1. Centrifugation
8.6.2. Chromatography
8.6.3. Electrophoresis
8.7. Sequencing
8.7.1. Ngs
8.7.2. Sanger
9. Biological Reagents Market, by Source
9.1. Introduction
9.2. Natural
9.3. Recombinant
9.4. Synthetic
10. Biological Reagents Market, by Purity Grade
10.1. Introduction
10.2. Analytical
10.3. Bioanalytical
10.4. Clinical & Diagnostic
11. Biological Reagents Market, by Formulation
11.1. Introduction
11.2. Liquid
11.3. Lyophilized
11.4. Solid
12. Biological Reagents Market, by Application
12.1. Introduction
12.2. Diagnostics
12.2.1. Genetic Testing
12.2.2. Infectious Disease
12.2.3. Oncology
12.2.4. Point Of Care
12.3. Drug Discovery
12.3.1. Admet
12.3.2. Lead Optimization
12.3.3. Target Screening
12.4. Personalized Medicine
12.4.1. Companion Diagnostics
12.4.2. Pharmacogenomics
12.5. Research & Development
12.5.1. Cell Biology
12.5.2. Genomics
12.5.3. Proteomics
12.5.4. Structural Biology
13. Biological Reagents Market, by End User
13.1. Introduction
13.2. Academic & Government
13.3. Cros
13.4. Hospitals & Diagnostic Labs
13.5. Pharmaceutical & Biotechnology
14. Biological Reagents Market, by Distribution Channel
14.1. Introduction
14.2. Direct Sales
14.3. Distributors
14.4. Online
15. Biological Reagents Market, by Region
15.1. Introduction
15.2. Asia-Pacific
15.3. North America
15.4. Latin America
15.5. Europe
15.6. Middle East
15.7. Africa
16. Biological Reagents Market, by Group
16.1. Introduction
16.2. ASEAN
16.3. GCC
16.4. European Union
16.5. BRICS
16.6. G7
16.7. NATO
17. Biological Reagents Market, by Country
17.1. Introduction
17.2. United States
17.3. Canada
17.4. Mexico
17.5. Brazil
17.6. United Kingdom
17.7. Germany
17.8. France
17.9. Russia
17.10. Italy
17.11. Spain
17.12. China
17.13. India
17.14. Japan
17.15. Australia
17.16. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. Market Concentration Analysis, 2025
18.2.1. Concentration Ratio (CR)
18.2.2. Herfindahl Hirschman Index (HHI)
18.3. Recent Developments & Impact Analysis, 2025
18.4. Product Portfolio Analysis, 2025
18.5. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Abbott Laboratories
19.2. Agilent Technologies, Inc.
19.3. Becton, Dickinson and Company
19.4. Bio-Rad Laboratories, Inc.
19.5. BioMérieux SA
19.6. Bio-Techne Corporation
19.7. Bruker Corporation
19.8. Danaher Corporation
19.9. Illumina, Inc.
19.10. Lonza Group AG
19.11. Merck KGaA
19.12. Miltenyi Biotec
19.13. New England Biolabs
19.14. PerkinElmer, Inc.
19.15. Promega Corporation
19.16. QIAGEN N.V.
19.17. Roche Holding AG
19.18. Shimadzu Corporation
19.19. Siemens Healthineers
19.20. STEMCELL Technologies
19.21. Sysmex Corporation
19.22. Takara Bio, Inc.
19.23. Thermo Fisher Scientific Inc.
19.24. Waters Corporation
20. Key Experts
LIST OF FIGURES
FIGURE 1. Global Biological Reagents Market, Years Considered for the Study
FIGURE 2. Global Biological Reagents Market, Research Design
FIGURE 3. Global Biological Reagents Market, Research Framework
FIGURE 4. Global Biological Reagents Market, Data Triangulation
FIGURE 5. Global Biological Reagents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Biological Reagents Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Biological Reagents Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Biological Reagents Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Biological Reagents Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Biological Reagents Market Size, by Source, 2025 vs 2032 (%)
FIGURE 11. Global Biological Reagents Market Size, by Source, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Biological Reagents Market Size, by Purity Grade, 2025 vs 2032 (%)
FIGURE 13. Global Biological Reagents Market Size, by Purity Grade, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Biological Reagents Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 15. Global Biological Reagents Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Biological Reagents Market Size, by Application, 2025 vs 2032 (%)
FIGURE 17. Global Biological Reagents Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Biological Reagents Market Size, by End User, 2025 vs 2032 (%)
FIGURE 19. Global Biological Reagents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Biological Reagents Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 21. Global Biological Reagents Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Biological Reagents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 23. Global Biological Reagents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Biological Reagents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Biological Reagents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 26. Global Biological Reagents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Biological Reagents Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Biological Reagents Market Segmentation & Coverage
TABLE 2. Global Biological Reagents Market Size, 2017-2032 (USD Million)
TABLE 3. Global Biological Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Monoclonal Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Monoclonal Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Monoclonal Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Mouse Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Mouse Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Mouse Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Rabbit Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Rabbit Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Rabbit Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Polyclonal Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Polyclonal Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Polyclonal Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Goat Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Goat Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Goat Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Rabbit Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Rabbit Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Rabbit Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Cell Culture Media & Sera Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Cell Culture Media & Sera Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Cell Culture Media & Sera Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Basal Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Basal Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Basal Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Sera Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Sera Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Sera Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Supplements Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Ligases Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Ligases Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Ligases Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Polymerases Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Polymerases Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Polymerases Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Restriction Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Restriction Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Restriction Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Kits & Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Kits & Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Kits & Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Elisa Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Elisa Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Elisa Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Immunoassay Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Immunoassay Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Immunoassay Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Pcr Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Pcr Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Pcr Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Sequencing Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Sequencing Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Sequencing Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Nucleic Acids Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Nucleic Acids Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Nucleic Acids Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Dna Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Dna Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Dna Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Oligonucleotides Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Oligonucleotides Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Oligonucleotides Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Rna Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Rna Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Rna Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Probes & Dyes Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Probes & Dyes Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Probes & Dyes Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Chromogenic Dyes Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Chromogenic Dyes Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Chromogenic Dyes Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Fluorescent Probes Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Fluorescent Probes Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Fluorescent Probes Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Radioactive Probes Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Radioactive Probes Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Radioactive Probes Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Biological Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 89. Global Flow Cytometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Flow Cytometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Flow Cytometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Labeling & Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Labeling & Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Labeling & Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Colorimetry Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Colorimetry Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Colorimetry Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Fluorescence Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Fluorescence Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Fluorescence Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Luminescence Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Luminescence Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Luminescence Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Pcr & Qpcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Pcr & Qpcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Pcr & Qpcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Separation & Purification Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Separation & Purification Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Separation & Purification Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Centrifugation Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Centrifugation Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Centrifugation Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Electrophoresis Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Electrophoresis Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Electrophoresis Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Ngs Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Ngs Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Ngs Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Sanger Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Sanger Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Sanger Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Biological Reagents Market Size, by Source, 2017-2032 (USD Million)
TABLE 132. Global Natural Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Natural Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Natural Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Recombinant Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Recombinant Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Recombinant Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Synthetic Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Synthetic Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Synthetic Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Biological Reagents Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 142. Global Analytical Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Analytical Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Analytical Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Bioanalytical Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Bioanalytical Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Bioanalytical Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Clinical & Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Clinical & Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Clinical & Diagnostic Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Biological Reagents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 152. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global Lyophilized Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global Lyophilized Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global Lyophilized Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Solid Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Global Solid Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. Global Solid Market Size, by Country, 2017-2032 (USD Million)
TABLE 161. Global Biological Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 165. Global Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Global Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. Global Genetic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 168. Global Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Global Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. Global Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 172. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 174. Global Point Of Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 175. Global Point Of Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. Global Point Of Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 177. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 180. Global Admet Market Size, by Region, 2017-2032 (USD Million)
TABLE 181. Global Admet Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. Global Admet Market Size, by Country, 2017-2032 (USD Million)
TABLE 183. Global Lead Optimization Market Size, by Region, 2017-2032 (USD Million)
TABLE 184. Global Lead Optimization Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. Global Lead Optimization Market Size, by Country, 2017-2032 (USD Million)
TABLE 186. Global Target Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Global Target Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. Global Target Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 189. Global Personalized Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 190. Global Personalized Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. Global Personalized Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 192. Global Companion Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 193. Global Companion Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 194. Global Companion Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 195. Global Pharmacogenomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 196. Global Pharmacogenomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. Global Pharmacogenomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 198. Global Research & Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 199. Global Research & Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 200. Global Research & Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 201. Global Cell Biology Market Size, by Region, 2017-2032 (USD Million)
TABLE 202. Global Cell Biology Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. Global Cell Biology Market Size, by Country, 2017-2032 (USD Million)
TABLE 204. Global Genomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 205. Global Genomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 206. Global Genomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 207. Global Proteomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 208. Global Proteomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 209. Global Proteomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 210. Global Structural Biology Market Size, by Region, 2017-2032 (USD Million)
TABLE 211. Global Structural Biology Market Size, by Group, 2017-2032 (USD Million)
TABLE 212. Global Structural Biology Market Size, by Country, 2017-2032 (USD Million)
TABLE 213. Global Biological Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Global Academic & Government Market Size, by Region, 2017-2032 (USD Million)
TABLE 215. Global Academic & Government Market Size, by Group, 2017-2032 (USD Million)
TABLE 216. Global Academic & Government Market Size, by Country, 2017-2032 (USD Million)
TABLE 217. Global Cros Market Size, by Region, 2017-2032 (USD Million)
TABLE 218. Global Cros Market Size, by Group, 2017-2032 (USD Million)
TABLE 219. Global Cros Market Size, by Country, 2017-2032 (USD Million)
TABLE 220. Global Hospitals & Diagnostic Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 221. Global Hospitals & Diagnostic Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 222. Global Hospitals & Diagnostic Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 223. Global Pharmaceutical & Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 224. Global Pharmaceutical & Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 225. Global Pharmaceutical & Biotechnology Market Size, by Country, 2017-2032 (USD Million)
TABLE 226. Global Biological Reagents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 227. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 228. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 230. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 231. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 232. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 233. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 234. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 235. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 236. Global Biological Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 237. Asia-Pacific Biological Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 238. Asia-Pacific Biological Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 239. Asia-Pacific Biological Reagents Market Size, by Antibodies, 2017-2032 (USD Million)
TABLE 240. Asia-Pacific Biological Reagents Market Size, by Monoclonal, 2017-2032 (USD Million)
TABLE 241. Asia-Pacific Biological Reagents Market Size, by Polyclonal, 2017-2032 (USD Million)
TABLE 242. Asia-Pacific Biological Reagents Market Size, by Cell Culture Media & Sera, 2017-2032 (USD Million)
TABLE 243. Asia-Pacific Biological Reagents Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 244. Asia-Pacific Biological Reagents Market Size, by Kits & Assays, 2017-2032 (USD Million)
TABLE 245. Asia-Pacific Biological Reagents Market Size, by Nucleic Acids, 2017-2032 (USD Million)
TABLE 246. Asia-Pacific Biological Reagents Market Size, by Probes & Dyes, 2017-2032 (USD Million)
TABLE 247. Asia-Pacific Biological Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 248. Asia-Pacific Biological Reagents Market Size, by Labeling & Detection, 2017-2032 (USD Million)
TABLE 249. Asia-Pacific Biological Reagents Market Size, by Separation & Purification, 2017-2032 (USD Million)
TABLE 250. Asia-Pacific Biological Reagents Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 251. Asia-Pacific Biological Reagents Market Size, by Source, 2017-2032 (USD Million)
TABLE 252. Asia-Pacific Biological Reagents Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 253. Asia-Pacific Biological Reagents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 254. Asia-Pacific Biological Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 255. Asia-Pacific Biological Reagents Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 256. Asia-Pacific Biological Reagents Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 257. Asia-Pacific Biological Reagents Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 258. Asia-Pacific Biological Reagents Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 259. Asia-Pacific Biological Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. Asia-Pacific Biological Reagents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 261. North America Biological Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 262. North America Biological Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 263. North America Biological Reagents Market Size, by Antibodies, 2017-2032 (USD Million)
TABLE 264. North America Biological Reagents Market Size, by Monoclonal, 2017-2032 (USD Million)
TABLE 265. North America Biological Reagents Market Size, by Polyclonal, 2017-2032 (USD Million)
TABLE 266. North America Biological Reagents Market Size, by Cell Culture Media & Sera, 2017-2032 (USD Million)
TABLE 267. North America Biological Reagents Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 268. North America Biological Reagents Market Size, by Kits & Assays, 2017-2032 (USD Million)
TABLE 269. North America Biological Reagents Market Size, by Nucleic Acids, 2017-2032 (USD Million)
TABLE 270. North America Biological Reagents Market Size, by Probes & Dyes, 2017-2032 (USD Million)
TABLE 271. North America Biological Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 272. North America Biological Reagents Market Size, by Labeling & Detection, 2017-2032 (USD Million)
TABLE 273. North America Biological Reagents Market Size, by Separation & Purification, 2017-2032 (USD Million)
TABLE 274. North America Biological Reagents Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 275. North America Biological Reagents Market Size, by Source, 2017-2032 (USD Million)
TABLE 276. North America Biological Reagents Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 277. North America Biological Reagents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 278. North America Biological Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 279. North America Biological Reagents Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 280. North America Biological Reagents Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 281. North America Biological Reagents Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 282. North America Biological Reagents Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 283. North America Biological Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. North America Biological Reagents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 285. Latin America Biological Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 286. Latin America Biological Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 287. Latin America Biological Reagents Market Size, by Antibodies, 2017-2032 (USD Million)
TABLE 288. Latin America Biological Reagents Market Size, by Monoclonal, 2017-2032 (USD Million)
TABLE 289. Latin America Biological Reagents Market Size, by Polyclonal, 2017-2032 (USD Million)
TABLE 290. Latin America Biological Reagents Market Size, by Cell Culture Media & Sera, 2017-2032 (USD Million)
TABLE 291. Latin America Biological Reagents Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 292. Latin America Biological Reagents Market Size, by Kits & Assays, 2017-2032 (USD Million)
TABLE 293. Latin America Biological Reagents Market Size, by Nucleic Acids, 2017-2032 (USD Million)
TABLE 294. Latin America Biological Reagents Market Size, by Probes & Dyes, 2017-2032 (USD Million)
TABLE 295. Latin America Biological Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 296. Latin America Biological Reagents Market Size, by Labeling & Detection, 2017-2032 (USD Million)
TABLE 297. Latin America Biological Reagents Market Size, by Separation & Purification, 2017-2032 (USD Million)
TABLE 298. Latin America Biological Reagents Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 299. Latin America Biological Reagents Market Size, by Source, 2017-2032 (USD Million)
TABLE 300. Latin America Biological Reagents Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 301. Latin America Biological Reagents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 302. Latin America Biological Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 303. Latin America Biological Reagents Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 304. Latin America Biological Reagents Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 305. Latin America Biological Reagents Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 306. Latin America Biological Reagents Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 307. Latin America Biological Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. Latin America Biological Reagents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 309. Europe Biological Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 310. Europe Biological Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 311. Europe Biological Reagents Market Size, by Antibodies, 2017-2032 (USD Million)
TABLE 312. Europe Biological Reagents Market Size, by Monoclonal, 2017-2032 (USD Million)
TABLE 313. Europe Biological Reagents Market Size, by Polyclonal, 2017-2032 (USD Million)
TABLE 314. Europe Biological Reagents Market Size, by Cell Culture Media & Sera, 2017-2032 (USD Million)
TABLE 315. Europe Biological Reagents Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 316. Europe Biological Reagents Market Size, by Kits & Assays, 2017-2032 (USD Million)
TABLE 317. Europe Biological Reagents Market Size, by Nucleic Acids, 2017-2032 (USD Million)
TABLE 318. Europe Biological Reagents Market Size, by Probes & Dyes, 2017-2032 (USD Million)
TABLE 319. Europe Biological Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 320. Europe Biological Reagents Market Size, by Labeling & Detection, 2017-2032 (USD Million)
TABLE 321. Europe Biological Reagents Market Size, by Separation & Purification, 2017-2032 (USD Million)
TABLE 322. Europe Biological Reagents Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 323. Europe Biological Reagents Market Size, by Source, 2017-2032 (USD Million)
TABLE 324. Europe Biological Reagents Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 325. Europe Biological Reagents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 326. Europe Biological Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 327. Europe Biological Reagents Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 328. Europe Biological Reagents Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 329. Europe Biological Reagents Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 330. Europe Biological Reagents Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 331. Europe Biological Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 332. Europe Biological Reagents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 333. Middle East Biological Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 334. Middle East Biological Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 335. Middle East Biological Reagents Market Size, by Antibodies, 2017-2032 (USD Million)
TABLE 336. Middle East Biological Reagents Market Size, by Monoclonal, 2017-2032 (USD Million)
TABLE 337. Middle East Biological Reagents Market Size, by Polyclonal, 2017-2032 (USD Million)
TABLE 338. Middle East Biological Reagents Market Size, by Cell Culture Media & Sera, 2017-2032 (USD Million)
TABLE 339. Middle East Biological Reagents Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 340. Middle East Biological Reagents Market Size, by Kits & Assays, 2017-2032 (USD Million)
TABLE 341. Middle East Biological Reagents Market Size, by Nucleic Acids, 2017-2032 (USD Million)
TABLE 342. Middle East Biological Reagents Market Size, by Probes & Dyes, 2017-2032 (USD Million)
TABLE 343. Middle East Biological Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 344. Middle East Biological Reagents Market Size, by Labeling & Detection, 2017-2032 (USD Million)
TABLE 345. Middle East Biological Reagents Market Size, by Separation & Purification, 2017-2032 (USD Million)
TABLE 346. Middle East Biological Reagents Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 347. Middle East Biological Reagents Market Size, by Source, 2017-2032 (USD Million)
TABLE 348. Middle East Biological Reagents Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 349. Middle East Biological Reagents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 350. Middle East Biological Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 351. Middle East Biological Reagents Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 352. Middle East Biological Reagents Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 353. Middle East Biological Reagents Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 354. Middle East Biological Reagents Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 355. Middle East Biological Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 356. Middle East Biological Reagents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 357. Africa Biological Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 358. Africa Biological Reagents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 359. Africa Biological Reagents Market Size, by Antibodies, 2017-2032 (USD Million)
TABLE 360. Africa Biological Reagents Market Size, by Monoclonal, 2017-2032 (USD Million)
TABLE 361. Africa Biological Reagents Market Size, by Polyclonal, 2017-2032 (USD Million)
TABLE 362. Africa Biological Reagents Market Size, by Cell Culture Media & Sera, 2017-2032 (USD Million)
TABLE 363. Africa Biological Reagents Market Size, by Enzymes, 2017-2032 (USD Million)
TABLE 364. Africa Biological Reagents Market Size, by Kits & Assays, 2017-2032 (USD Million)
TABLE 365. Africa Biological Reagents Market Size, by Nucleic Acids, 2017-2032 (USD Million)
TABLE 366. Africa Biological Reagents Market Size, by Probes & Dyes, 2017-2032 (USD Million)
TABLE 367. Africa Biological Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 368. Africa Biological Reagents Market Size, by Labeling & Detection, 2017-2032 (USD Million)
TABLE 369. Africa Biological Reagents Market Size, by Separation & Purification, 2017-2032 (USD Million)
TABLE 370. Africa Biological Reagents Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 371. Africa Biological Reagents Market Size, by Source, 2017-2032 (USD Million)
TABLE 372. Africa Biological Reagents Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 373. Africa Biological Reagents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 374. Africa Biological Reagents Market Size, by Application, 2017-2032 (USD Million)
TABLE 375. Africa Biological Reagents Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 376. Africa Biological Reagents Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 377. Africa Biological Reagents Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 378. Africa Biological Reagents Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 379. Africa Biological Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 380. Africa Biological Reagents Market Size, by Distribution Channel, 2017-2032 (USD Milli

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioMérieux SA
  • Bio‑Techne Corporation
  • Bruker Corporation
  • Danaher Corporation
  • Illumina, Inc.
  • Lonza Group AG
  • Merck KGaA
  • Miltenyi Biotec
  • New England Biolabs
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Roche Holding AG
  • Shimadzu Corporation
  • Siemens Healthineers
  • STEMCELL Technologies
  • Sysmex Corporation
  • Takara Bio, Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation